Characterization of the Clinical and Sensory Phenotype of Women with Lipedema and Their Family Members

Registry ID
DRKS00041187
Source registry
DRKS
Status
PENDING
Sponsor
Translationale Schmerzforschung, Klinik für Anästhesiologie und Operative Intensivmedizin, Uniklinik Köln, Universität zu Köln
Enrollment
40
Start date
2026-08-01
Completion date
2028-12-31
Last update
2026-07-30

Conditions

Inclusion criteria

General Requirements: • A signed and irrevocable consent form from the patient or her legal guardians (parents) • Family relationship to the lipedema patient (1st to 4th degree) For lipedema patients: • Medical diagnosis of lipedema in accordance with the new S2k guideline • Family spanning at least 2 generations For healthy male and female participants: • No medical diagnosis of lipedema

Exclusion criteria

- Impaired communication ability (language barriers, cognitive barriers, changes associated with dementia, …) - Conditions that affect the sensory nervous system (e.g., Parkinson’s disease, multiple sclerosis, radiculopathy, injuries to nerves innervating the measurement area of various etiologies, peripheral polyneuropathies of various etiologies, diabetes mellitus, …) - Skin conditions affecting the measurement sites (e.g., psoriasis) - Topical application of analgesics to the measurement sites (e.g., patches, creams, etc.) - Other known alterations in pain perception or another diagnosed pain disorder - Diagnosed depression - Liposuction performed prior to study enrollment - Pregnancy and breastfeeding

Primary outcomes

Conducting a family study that quantifies the prevalence of lipedema within families. Specifically, changes in various sensory modalities including pressure pain thresholds and vibration detection thresholds will be characterized in women with lipedema and their family members (siblings, children, parents) compared to control subjects of similar height, using quantitative sensory testing. Which family members, and at what ages, exhibit altered sensory thresholds?

Locations

Related clinical trials

View on source registry